Issues with valsartan continue despite investigations and... By James L. Ferraro | Pharmaceutical Litigation | Last Modified on Feb 20, 2026 Read More
Should the Food and Drug Administration recall... By James L. Ferraro | Pharmaceutical Litigation | Last Modified on Feb 27, 2026 Read More
Can you hold a drug company responsible... By James L. Ferraro | Pharmaceutical Litigation | Last Modified on Feb 20, 2026 Read More
Nizatidine added to list of medications recalled... By James L. Ferraro | Pharmaceutical Litigation | Last Modified on Feb 20, 2026 Read More
Could another over-the-counter medication cause cancer? By James L. Ferraro | Pharmaceutical Litigation | Last Modified on Feb 20, 2026 Read More
The new year brings in more heartburn... By James L. Ferraro | Pharmaceutical Litigation | Last Modified on Feb 23, 2026 Read More
Understanding why drug recalls happen By James L. Ferraro | Pharmaceutical Litigation | Last Modified on Apr 07, 2026 Read More
FDA approval doesn’t guarantee a medication is... By James L. Ferraro | Pharmaceutical Litigation | Last Modified on Apr 07, 2026 Read More
Can the Zantac recall save others from... By James L. Ferraro | Pharmaceutical Litigation | Last Modified on Feb 20, 2026 Read More
Zantac wasn’t the first ranitidine drug to... By James L. Ferraro | Pharmaceutical Litigation | Last Modified on Feb 20, 2026 Read More
Food and Drug Administration expands NDMA testing... By James L. Ferraro | Pharmaceutical Litigation | Last Modified on Feb 21, 2026 Read More
What NDMA is and what overexposure looks... By James L. Ferraro | Pharmaceutical Litigation | Last Modified on Feb 27, 2026 Read More